Business · 08/03/2004
FDA Clears LOVENOX for Approval of Generic Versions
The FDA has determined that LOVENOX (enoxaparin sodium) 90 mg/0.6 mL was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of generic versions of the medication.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →